The 2024 NANETS Multidisciplinary NET Medical Symposium was held from November 21-23, 2024, at the Chicago Marriott Downtown Magnificent Mile.
This event brought together leading experts in the field of neuroendocrine tumors (NETs) to share the latest advancements in research, treatment, and patient care. The symposium featured a variety of educational sessions, presentations, and networking opportunities for medical professionals dedicated to improving NET outcomes.
The North American Neuroendocrine Tumor Society (NANETS) is a professional society of nearly 600 medical experts focused on improving the treatment of neuroendocrine tumors (NETs). NANETS provides accredited educational programs developed by leading NET specialists for healthcare professionals. The society is committed to advancing research, developing treatment guidelines, and mentoring emerging professionals in the field. Through these efforts, NANETS supports the ongoing progress of NET science and education across North America.
NANETS:
“Day 1 at NANETS 2024 continues to exceed expectations with packed workshops, live podcasting sessions, and dynamic research presentations. The energy in Chicago remains high as experts engage in critical discussions advancing NET patient care. Join us tomorrow as we build on today’s momentum.”
Pamela Kunz:
“So proud of my mentees and their poster presentation at NANETS24
Dr. Shagufta Shaheen
Dr. Wan-Ying Tan.”
Sabha Ganai:
“Great talk by Caroline Rieser on inequities in care and accessibility in multidisciplinary management of GEP-NETS.”
Namrata (Neena) Vijayvergia:
“Building on the success from previous years… so excited to have Shikha Jain talk about Brand building for career growth at the NANETS2024 Women In NETs luncheon. Mark your calendar if you are at NANETS.”
NANETS:
“The energy at NANETS2024 Day 1 remains electric with packed workshops, live podcasting & cutting-edge NET research presentations. follow us tomorrow in Chicago as leading experts continue advancing patient care & fostering collaboration.”
Lisa Yen:
“Congrats Udhayvir Grewal, winner of the NANETS24 Best Scientific Poster Award for your Racial Inequities in NET Trial Enrollment in the US! What important work!”
Sabha Ganai:
“What is your brand? What do people say about you when you are not in the room?”
Junaid Arshad:
“Heartfelt congrats to my incredible mentor, Dr. Pam Kunz on receiving the Distinguished Mentor Award at NANETS24. A lifetime of guidance, inspiration, and unwavering support has shaped countless careers.”
Po Hien Ear:
“Tremendous gratitude forwards NET Research Foundation and Elyse Gellerman for always supporting NET Research!!!”
Lisa Yen:
“NANETS saved the best for last: The Great Debate: NETTER2: Lu177-dotatate 1L or 2+ for ki67>10%. Major, Marine Corps Ashley nailed it with the probability risk calculus discussion.”
Samira Sadowski:
“Very proud of my team presenting their work about model and microenvironment in GEP-NET
Steven Forsythe, Srujana Yellapragada.”
Julie Hallet:
“Next big things in NETs care Mauro Cives at NANETS24
– new PRRT regimens: alpha-emiting RLT,
– BiTEs for NEC
– CAR T cell therapy
– tumor vaccines.”
Samantha Greenberg:
“Emil Lou discussing how social media has impacted our networking/ connections in medicine. Which means it’s officially NANETS24! Excited for NET nerdiness…
And also, on the 5 year anniversary of my first X account: it’s blue sky time!”
Lisa Yen:
“Congrats to my dear friend and LACNETS Medical Advisor Jaydi Del Rivero for the well-deserved Distinguished Clinician Award. Thank you for your dedication to the NET patient community! You are a super star.”
Julie Hallet:
“Mexico proudly represented at NANETS24!! So happy to see the community grow across all of North America especially proud of UofT Surgical Oncology, Gabriela Alejandra Buerba building surgical NETs program after fellowship.”
Sabha Ganai:
“‘Just radiate it’ – Ralph Weichselbaum
Great advice on starting a translational science program from Xavier Keutgen.”
Udhayvir Grewal:
“A huge shoutout to the amazing Dr. Po Hien Ear for Co-chairing the NANETS24 symposium committee and helping put together one of the largest events in the recent history of NANETS! Thanks for also representing us at UI Holden Comprehensive Cancer Center so well, as always. I’m proud to be a part of the team that is led by leaders like Dr Ear.”
NANETS:
“Day 2 at NANETS2024 is in full swing. The collaborative spirit among attendees continues to drive meaningful discussions! Stay tuned for today’s highlights from Chicago. Let’s keep this momentum going!”
Thor Halfdanarson:
“Oral presentations at NANETS24 ongoing. Two young/early career researchers, Lizeth Estrada (med student at UCSF School of Medicine) and Dr. Rushabh Gujarathi (post-doc scholar at U of Chicago). Both presenting for the first time at a conference. The future is bright!”
Lisa Yen:
“NANETS24 Day 3: Fascinating oral abstracts linking genes to phenotypes to NETS, highlights the value of NGS testing.”
Tanaz Vaghaiwalla:
“Proud of our UM/JMH General Surgery chief resident and future endocrine surgeon Dr. Amber Collier for her poster NANETS shedding light on survival outcomes associated with distance traveled and hospital volumes for patients with WD PNETs!”
Udhayvir Grewal:
“I am so happy to receive the “Best Scientific Poster Award (Clinical Research) at the NANETS annual symposium NANETS24. Thanks to my amazing team at UI Holden Comprehensive Cancer Center and most importantly my wonderful mentor and GI Oncology/NET Guru Chandrikha Chandrasekharan.
I wouldn’t be here today without her constant guidance and support. Congratulations to Osama Mosalem and Brittany C. Fields for their awards as well! So much to look forward to!!”
Tanaz Vaghaiwalla:
“A full house on the final day of NANETS featuring incredible NET research! Congrats Dr. Rushabh Gujarathi for your talk on MEN1/DAXX alterations associated with improved OS and Tx response in PNETS.”
Lisa Yen:
“Heading home from an inspiring NANETS24 with a full heart and clear eyes. Thanks NANETS and organizers Po Hien Ear, Daneng Li, Chandrikha Chandrasekharan and advocates”
For more posts like this visit oncodaily.com